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A commentary on
Why has the BMI gone up so drastically in 
the last 35 years?
by Lindberg, M. A., Dementieva, Y., and 
Cavender, J. (2011). J. Addict. Med. 5, 
272–278.
A recent study by Lindberg et al. (2011) in 
the Journal of Addiction Medicine aimed at 
answering a specific question, i.e., if some 
food groups or additives have been more 
responsible than others in the dramatic 
increase in body mass index (BMI) during 
the last decades. This study demonstrated 
that the additives of fats and sugars in 
combination, not separately, best predicted 
increases in BMI accounting for 97% of the 
variance in the linear regression analyses. 
Lindberg et al. (2011) conclude highlighting 
the importance of palatability as the addic-
tive trigger, as fats and sugars in combination 
rather than calories per se or particular food 
groups accounted for the increases in BMI.
The authors of this study have to be com-
mended as they conducted a complex study 
analyzing archival data related to a 35-year 
period from the United States Department 
of Agriculture and the Center for Disease 
Control (Lindberg et al., 2011). Their results 
are consistent with the increasing evidence 
that obesity represents an emerging addic-
tive disorder. In particular, this study clearly 
points out the importance of palatability as 
the addictive trigger in obese individuals. 
These findings based on archival data are 
consistent with imaging studies showing 
the  importance of food palatability in the 
neurobiology of obesity. For example, Wang 
et al. (2009) demonstrated that the reduction 
in dopamine D2 receptors in obese subjects 
coupled with the enhanced sensitivity to food 
palatability could be responsible for making 
food their most salient reinforcer putting 
them at risk for compulsive eating and obesity.
Lindberg et al.’s (2011) study provides 
further convincing evidence that obesity 
needs to be considered not only a  metabolic 
and endocrine disorder, but also a behavio-
ral and psychiatric disorder. The diagnostic 
and statistical manual of mental disorders 
(DSM), for example, is moving toward this 
direction (e.g., see Volkow and O’Brien, 
2007). Just to cite an example (among the 
many examples that could be mentioned), 
there is a high comorbidity among addic-
tive disorders, and sweet likers, as com-
pared to sweet dislikers, are at higher risk 
for developing alcohol-related problems 
(e.g., Kampov-Polevoy et al., 2003). These 
findings (reviewed in Leggio et al., 2011) 
are interesting because not only they iden-
tify a specific endophenotype, but also they 
highlight how sweet preference is strongly 
linked to another addictive disorder (e.g., 
alcoholism), further pointing out the addic-
tive properties of a palatable behavior such 
as a sweet-liking behavior.
The take home message is that there is 
a crucial need for a more comprehensive 
management of obese patients. Asking these 
patients to reduce their food intake is not 
enough; rather it is important to consider 
treatment approaches that target palatabil-
ity as the addictive trigger responsible for 
the persistence and increased prevalence of 
obesity. This has been and is still a challenge 
because of the need for identifying treatment 
approaches (e.g., pharmacotherapies), which 
are both safe and effective. Nonetheless, 
research is moving toward this direction. 
For example, despite the recent removal of 
rimonabant, researchers are making efforts 
to demonstrate the ability of other pharma-
cotherapies to selectively reduce motivation 
to obtain highly palatable reinforcers (e.g., 
CB1 antagonists Droste et al., 2010).
Therefore, consistent with the increas-
ing need for a more personalized medi-
cine (Malandrino and Smith, 2011) it is 
more and more important to develop a 
more integrated approach in the man-
agement of obese patients, including 
the need to follow-up these patients by 
team players coming from different fields 
(e.g., endocrinology and metabolism, psy-
chiatry, addiction medicine, behavioral 
medicine).
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